DE69830114D1 - Analgetische Zusammensetzung welche Moxonidine und ein Opioid-Analgetika enthält - Google Patents

Analgetische Zusammensetzung welche Moxonidine und ein Opioid-Analgetika enthält

Info

Publication number
DE69830114D1
DE69830114D1 DE69830114T DE69830114T DE69830114D1 DE 69830114 D1 DE69830114 D1 DE 69830114D1 DE 69830114 T DE69830114 T DE 69830114T DE 69830114 T DE69830114 T DE 69830114T DE 69830114 D1 DE69830114 D1 DE 69830114D1
Authority
DE
Germany
Prior art keywords
analgesic
opioid
composition containing
moxonidine
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69830114T
Other languages
English (en)
Inventor
Carolyn A Fairbanks
George L Wilcox
Laura S Stone
Kelley F Kitto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Solvay Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals GmbH filed Critical Solvay Pharmaceuticals GmbH
Application granted granted Critical
Publication of DE69830114D1 publication Critical patent/DE69830114D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69830114T 1997-09-16 1998-09-14 Analgetische Zusammensetzung welche Moxonidine und ein Opioid-Analgetika enthält Expired - Lifetime DE69830114D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5895497P 1997-09-16 1997-09-16

Publications (1)

Publication Number Publication Date
DE69830114D1 true DE69830114D1 (de) 2005-06-16

Family

ID=22019930

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69830114T Expired - Lifetime DE69830114D1 (de) 1997-09-16 1998-09-14 Analgetische Zusammensetzung welche Moxonidine und ein Opioid-Analgetika enthält

Country Status (4)

Country Link
US (1) US6204271B1 (de)
EP (1) EP0906757B1 (de)
AT (1) ATE295171T1 (de)
DE (1) DE69830114D1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003061688A1 (fr) * 2002-01-21 2003-07-31 Nrl Pharma, Inc. Nouveaux analgesiques
PL372695A1 (en) * 2002-06-19 2005-07-25 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
US20050058734A1 (en) * 2002-12-18 2005-03-17 Algorx Administration of capsaicinoids
ES2562025T3 (es) * 2002-12-18 2016-03-02 Centrexion Therapeutics Corporation Administración de capsaicinoides para el tratamiento de la artrosis
WO2004092122A2 (en) * 2003-04-08 2004-10-28 Algorx Pharmaceuticals, Inc. Preparation and purification of synthetic capsaicin
US20060148903A1 (en) * 2004-11-24 2006-07-06 Algorx Pharmaceuticals, Inc. Capsaicinoid gel formulation and uses thereof
EP2493877B1 (de) * 2009-10-30 2014-09-17 Janssen Pharmaceutica NV Pyrimidinverbindungen als delta-opioid-rezeptormodulatoren

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU166378B (de) * 1972-12-19 1975-03-28
US5840731A (en) * 1995-08-02 1998-11-24 Virginia Commonwealth University Pain-alleviating drug composition and method for alleviating pain

Also Published As

Publication number Publication date
EP0906757A3 (de) 2001-05-16
EP0906757B1 (de) 2005-05-11
EP0906757A2 (de) 1999-04-07
US6204271B1 (en) 2001-03-20
ATE295171T1 (de) 2005-05-15

Similar Documents

Publication Publication Date Title
DE69535445D1 (de) Schmelzextrudierte oral verabreichbare Opioidformulierungen
DE69822168D1 (de) Dentale anästhesie- und verabreichungsinjektionseinheit
NZ503233A (en) Synergistic analgesic combination of opioid analgesic and COX-2 inhibitor
HUP0002645A3 (en) Phospholipid containing pharmaceutical composition for treating sleep apnea and apparatus for enabling the administration thereof
FI954228A (fi) Infuusiolaite hoitoaineen jaksottaista tai jatkuvaa antamista varten
NZ336865A (en) Use of a therapeutic agent containing a neurotrophic factor for treatment of diabetes and hyperlipemia
ATE210983T1 (de) Stabilisiertes kombinationsarzneimittel enthaltend naloxone und ein opiatanalgetikum
CY2007001I2 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
EP0761173A3 (de) Nadel zum Verabreichen therapeutischer Lösungen in den Subarachnoidalraum
ATE283695T1 (de) Verwendungen und zusammenstellungen von nitratestern als sedativa
ATE243196T1 (de) Piperidine und pyrrolidine
ES2099344T3 (es) Preparado de combinacion a base de flupirtina y morfina para el tratamiento de dolores y para evitar la adiccion a morfina.
ITMI930582A0 (it) Composizione farmeceutiche ad attivita' analgesica
DE69830114D1 (de) Analgetische Zusammensetzung welche Moxonidine und ein Opioid-Analgetika enthält
ITMI931325A0 (it) Composizione farmaceutica ad attivita' analgesica
GB2305606B (en) Drug delivery composition for the nasal administration of ICAM-1
ZA968905B (en) Transdermal therapeutic system (tts) for administering active substances for drug dependence or drug addiction
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
EE03205B1 (et) Ropivakaiini kasutamine valuvaigistina kasutatava ravimpreparaadi valmistamiseks
DK408188D0 (da) Injicerbart middel til kontrolleret frigivelse af opioid-analgetika
HK1046847A1 (en) Pharmaceutical combination with analgesic action containing paracetamol and buspirone.
BR9801839A (pt) Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
HUP9903375A2 (hu) Olanzapint és fájdalomcsillapító hatóanyagot tartalmazó szinergista hatású gyógyszerkészítmények
SE9803623D0 (sv) New therapeutic application
IT1288708B1 (it) Composizione farmaceutica comprendente trometamina per il trattamento per via topica dell'acne vulgaris.

Legal Events

Date Code Title Description
8332 No legal effect for de